Ann: Appendix 4E and Annual Report, page-20

From what I see they have exceeded the expectations. UBS and Macquarie were expecting 7.0 & 8.4 cents as EPS (respectively) and the actual EPS is 9 cents.

"—EML is in dialogue with the CBI regarding restriction of material growth in PCSIL's business, with the expectation that such restrictions will only apply during the remediation phase ... —Any such restrictions are likely to affect the number of new programs PCSIL is permitted to launch while restrictions apply." (p27)

So the impact of CBI issues is limited to capping the growth of European business rather than eliminating the European Business as the market reaction was indicating. I was expecting less though. Hopefully, they can reinvigorate that growth engine within a year or so. They expect around 20% growth for 2022 (based on assumptions).